JP2022524992A5 - - Google Patents
Info
- Publication number
- JP2022524992A5 JP2022524992A5 JP2021552603A JP2021552603A JP2022524992A5 JP 2022524992 A5 JP2022524992 A5 JP 2022524992A5 JP 2021552603 A JP2021552603 A JP 2021552603A JP 2021552603 A JP2021552603 A JP 2021552603A JP 2022524992 A5 JP2022524992 A5 JP 2022524992A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- tcr
- acid sequence
- hla
- constant region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962813650P | 2019-03-04 | 2019-03-04 | |
| US62/813,650 | 2019-03-04 | ||
| PCT/IB2020/051812 WO2020178743A1 (en) | 2019-03-04 | 2020-03-03 | T cell receptors and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524992A JP2022524992A (ja) | 2022-05-11 |
| JP2022524992A5 true JP2022524992A5 (enExample) | 2023-03-13 |
| JP7727547B2 JP7727547B2 (ja) | 2025-08-21 |
Family
ID=72337378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552603A Active JP7727547B2 (ja) | 2019-03-04 | 2020-03-03 | Ｔ細胞受容体及びその使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220168346A1 (enExample) |
| EP (1) | EP3935171A4 (enExample) |
| JP (1) | JP7727547B2 (enExample) |
| KR (1) | KR20210144739A (enExample) |
| CN (1) | CN113785064B (enExample) |
| AU (1) | AU2020231928A1 (enExample) |
| BR (1) | BR112021017404A2 (enExample) |
| CA (1) | CA3132435A1 (enExample) |
| IL (1) | IL286042A (enExample) |
| MX (1) | MX2021010538A (enExample) |
| SG (1) | SG11202109594PA (enExample) |
| TW (1) | TWI877145B (enExample) |
| WO (1) | WO2020178743A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3935175A4 (en) | 2019-03-04 | 2023-01-04 | University Health Network | T-LYMPHOCYTE RECEPTORS AND METHODS OF USE THEREOF |
| CN113795584B (zh) | 2019-03-04 | 2025-09-30 | 大学健康网络 | T细胞受体及其使用方法 |
| KR20210144737A (ko) | 2019-03-04 | 2021-11-30 | 유니버시티 헬스 네트워크 | T 세포 수용체 및 이의 사용 방법 |
| MX2021011462A (es) | 2019-03-25 | 2021-12-15 | Univ Health Network | Receptores de linfocitos t y metodos de uso de los mismos. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2323632A1 (en) * | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
| WO2008089053A2 (en) * | 2007-01-12 | 2008-07-24 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Gp100-specific t cell receptors and related materials and methods of use |
| KR101363928B1 (ko) | 2007-06-11 | 2014-02-19 | 고쿠리츠다이가쿠호진 미에다이가쿠 | 특이적 유전자 발현 방법 |
| EP2337795A2 (en) * | 2008-10-01 | 2011-06-29 | Dako Denmark A/S | Mhc multimers in cancer vaccines and immune monitoring |
| US10441644B2 (en) * | 2015-05-05 | 2019-10-15 | The Regents Of The University Of California | H3.3 CTL peptides and uses thereof |
| MX2019003768A (es) * | 2016-10-03 | 2019-06-24 | Juno Therapeutics Inc | Moleculas de enlace especificas de hpv. |
-
2020
- 2020-03-03 US US17/436,939 patent/US20220168346A1/en active Pending
- 2020-03-03 KR KR1020217031549A patent/KR20210144739A/ko active Pending
- 2020-03-03 CA CA3132435A patent/CA3132435A1/en active Pending
- 2020-03-03 BR BR112021017404A patent/BR112021017404A2/pt unknown
- 2020-03-03 CN CN202080025509.5A patent/CN113785064B/zh active Active
- 2020-03-03 WO PCT/IB2020/051812 patent/WO2020178743A1/en not_active Ceased
- 2020-03-03 JP JP2021552603A patent/JP7727547B2/ja active Active
- 2020-03-03 MX MX2021010538A patent/MX2021010538A/es unknown
- 2020-03-03 SG SG11202109594P patent/SG11202109594PA/en unknown
- 2020-03-03 EP EP20765649.7A patent/EP3935171A4/en active Pending
- 2020-03-03 AU AU2020231928A patent/AU2020231928A1/en active Pending
- 2020-03-04 TW TW109107112A patent/TWI877145B/zh active
-
2021
- 2021-09-01 IL IL286042A patent/IL286042A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022527267A5 (enExample) | ||
| JP2022523554A5 (enExample) | ||
| JP2022524993A5 (enExample) | ||
| JP2022524994A5 (enExample) | ||
| JP2022523552A5 (enExample) | ||
| JP2022523971A5 (enExample) | ||
| JP2022523553A5 (enExample) | ||
| JP2022524992A5 (enExample) | ||
| Baxevanis et al. | Cancer immunotherapy | |
| Batlevi et al. | Novel immunotherapies in lymphoid malignancies | |
| EP2446897A1 (en) | Anti-KIR combination treatments and methods | |
| Shilyansky et al. | T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. | |
| Tsang et al. | Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen. | |
| RU2018147423A (ru) | Анти-PD-L1 и IL-2 цитокины | |
| US20170232070A1 (en) | Combination Methods for Immunotherapy | |
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| US11951131B2 (en) | Anti-SLAMF7 chimeric antigen receptors | |
| CN115747156A (zh) | 用于得到体内存留性和治疗活性的nkt细胞亚群以及其繁殖 | |
| JP2022543059A5 (enExample) | ||
| JP2020533962A5 (enExample) | ||
| CA3052803A1 (en) | Maximizing t-cell memory and compositions and methods therefor | |
| AU2020231694A1 (en) | T cell receptors and methods of use thereof | |
| JP2023542528A5 (enExample) | ||
| JP2022543060A5 (enExample) | ||
| JP2022543058A5 (enExample) |